Thermo Fisher Scientific (TMO) Non-Current Deferred Tax Liability (2009 - 2026)

Thermo Fisher Scientific has reported Non-Current Deferred Tax Liability for 18 years, with the latest figure at $1.6 billion in Q2 2026.

• Non-Current Deferred Tax Liability for Q2 2026 came in at $1.6 billion, up 153.04% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.6 billion (up 153.04% YoY), and the FY2025 annual result was $1.5 billion, up 17.74% from the prior year.
• Non-Current Deferred Tax Liability declined to $1.6 billion in Q2 2026, from $2.1 billion in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $3.5 billion in Q2 2022 and troughed at $624.0 million in Q2 2025.
• A 5-year average of $2.0 billion and a median of $1.9 billion in 2023 frame the typical range for Non-Current Deferred Tax Liability.
• The widest annual swing landed in 2025, when Non-Current Deferred Tax Liability plunged 58.84%; it then soared 153.04% in 2026.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $2.8 billion in 2022, then sank by 32.54% to $1.9 billion in 2023, then tumbled by 34.03% to $1.3 billion in 2024, then rose by 17.74% to $1.5 billion in 2025, then grew by 5.76% to $1.6 billion in 2026.
• Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $1.6 billion in Q2 2026, $2.1 billion in Q1 2026, and $1.5 billion in Q4 2025.